Á lódáil...
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer
PURPOSE: Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer. METHODS: miR-100...
Na minha lista:
| Foilsithe in: | ESMO Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BMJ Publishing Group
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7597498/ https://ncbi.nlm.nih.gov/pubmed/33122354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000937 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|